New lipase enzymes (both nucleic acids and polypeptides) are provided. Compositions which include these polypeptides, proteins, nucleic acids, recombinant cells, as well as methods involving the enzymes, antibodies to the enzymes, and methods of using the enzymes are also provided
Claims What is claimed is: 1. An isolated or recombinant polypeptide having lipase activity and comprising a sequence having at least 98% amino acid sequence identity to the mature region of SEQ ID:55. 2. The isolated or recombinant polypeptide of claim 1, wherein said polypeptide comprises a sequence selected from SEQ ID NO: 55 or the mature region thereof. 3. The isolated or recombinant polypeptide of claim 2, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 55. 4. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide exhibits lipase activity with respect to tributyrin. 5. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide exhibits lipase activity with respect to tributyrin in N,N-dimethylformamide (DMF). 6. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide exhibits lipase activity with respect to neryl-butyrate. 7. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide exhibits lipase activity with respect to geranyl-butyrate. 8. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide exhibits lipase activity with respect to pentadecanolide. 9. The isolated or recombinant polypeptide of claim 1, further comprising a leader sequence. 10. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide comprises a secretion signal or a localization signal. 11. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide comprises an epitope tag. 12. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide comprises a fusion protein comprising one or more additional amino acid sequences. 13. The isolated or recombinant polypeptide of claim 1, further comprising a polypeptide purification domain. 14. The isolated or recombinant polypeptide of claim 13, wherein the polypeptide purification domain is selected from the group consisting of: an epitope tag, a polyhistidine sequence, and a glutathione S-transferase (GST). 15. The isolated or recombinant polypeptide of claim 1, further comprising a methionine residue at the N-terminus. 16. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide further comprises a modified amino acid selected from the group consisting of: a glycosylated amino acid, a PEGylated amino acid, a farnesylated amino acid, an acetylated amino acid, a biotinylated amino acid, and an amino acid conjugated to a lipid moiety. 17. A composition comprising the isolated or recombinant polypeptide of claim 1 and a pharmaceutically acceptable excipient. 18. A composition comprising the isolated or recombinant polypeptide of claim 1 and a surfactant. 19. The composition of claim 18, further comprising one or more of: a builder, a polymer, a bleach system, a structruant, a pH adjuster, a humectant, or a neutral inorganic salt. 20. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide comprises one or more amino acid residues selected from the group consisting of Lys at position 1, Thr at position 14, Ser at position 17, Arg at position 22, Glu at position 26, Pro at position 31, Gly at position 33, Glu at position 34, Pro at position 35, Pro or Thr at position 37, Ser or Lys at position 41, Gly at position 42, Arg or Glu at position 43, Ala at position 61, Tyr at position 75, Gly at position 96, Ser at position 97, Thr at position 104, Ser at position 107, Ala at position 125, Gly at position 129, Val at position 134, Cys at position 138, Lys at position 141, Lys at position 146, Thr at position 156, Met at position 160, Arg at position 166, and His at position 177, wherein positions are equivalent amino acid positions with respect to SEQ ID NO: 75. 21. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide comprises one or more amino acid residues selected from the group consisting of Arg at position 22, Gly at position 33, Ser or Lys at position 41, Arg at position 43, Ser at position 107, Lys at position 141, Lys at position 146, Met at position 160, and His at position 177. 22. The isolated or recominant polypeptide of claim 21, wherein the polypeptide comprises one or more amino acid residues selected from the group consisting of Arg at position 43 and Ser at position 107. 23. The isolated or recombinant polypeptide of claim 1, wherein the polypeptide comprises one or more amino acid selected from the group consisting of Ser at position 17, Arg at position 22, Pro at position 31, Gly at position 33, Ser or Lys at position 41, Lys at position 141, Lys at position 146, Met at position 160, Arg at position 166, and His at position 177. 24. The isolated or recombinant polypeptide of claim 23, wherein the polypeptide comprises one or more amino acid residues selected from the group consising of Ser at position 17, Pro at position 31, and Arg at position 166. 25. An isolated or recombinant polypeptide exhibiting lipase activity, wherein the polypeptide is encoded by a polynucleotide that hybridizes under stringent conditions over substantially the entire length of the mature coding region of SEQ ID NO: 1, or complement thereof, wherein stringent hybridization conditions are 42.degree. C. overnight in 50% formamide with 1 mg heparin and a 0.2.times.SSC wash at 65.degree. C. for 15 minutes, and wherein the polypeptide comprises one or more amino acid residues selected from the group consisting of Lys at position 1, Thr at position 14, Ser at position 17, Arg at position 22, Glu at position 26, Pro at position 31, Gly at position 33, Glu at position 34, Pro at position 35, Pro or Thr at position 37, Ser or Lys at position 41, Gly at position 42, Arg or Glu at position 43, Ala at position 61, Tyr at position 75, Gly at position 96, Ser at position 97, Thr at position 104, Ser at position 107, Ala at position 125, Gly at position 129, Val at position 134, Cys at position 138, Lys at position 141, Lys at position 146, Thr at position 156, Met at position 160, Arg at position 166, and His at position 177, wherein the positions are equivalent amino acid positions with respect to SEQ ID NO: 75. 26. The isolated or recombinant polypeptide of claim 25, wherein the polypeptide comprises one or more amino acid residues selected from the group consisting of Arg at position 22, Gly at position 33, Ser or Lys at position 41, Arg at position 43, Ser at position 107, Lys at position 141, Lys at position 146, Met at position 160, and His at position 177. 27. The isolated or recombinant polypeptide of claim 26, wherein the polypeptide comprise or more amino acid residues selected from the group consisting of Arg at position 43 and Ser at position 107. 28. The isolated or recombinant polypeptide of claim 25, wherein the polypeptide comprises one or more amino acid residues selected from the group consisting of Ser at position 17, Arg at position 22, Pro at position 31, Gly at position 33, Ser or Lys at position 41, Lys at position 141, Lys at position 146, Met at position 160, Arg at position 166, and His at position 177. 29. The isolated or recombinant polypeptide of claim 28, wherein the polypeptide comprises one or more amino acid residues selected from the group consisting of Ser at position 17, Pro at position 31, and Arg at position 166. 30. A composition comprising the isolated or recombinant polypeptide of claim 25 and a surfactant. 31. The composition of claim 30, further comprising one or more of: a builder, a polymer, a bleach system, a structurant, a pH adjuster, a humectant, or a neutral inorganic salt. 